AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6700601
Drug: Chemotherapy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy without lithium carbonate
Trial: 30548118
Drug: M. officinalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M. officinalis capsules (700 mg/d)
Trial: 29798118
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment and psychological intervention
Trial: 29798118
Drug: Pure drug
RxNorm normalized name: Dream Pure BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure drug therapy (Control)
Trial: 25087210
Drug: Pelvic floor
RxNorm normalized name: Tenscare Kegel Toner Pelvic Floor Trainer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic floor muscle training, device training and home treatment (experimental group)
Trial: 16809572
Drug: Geranylgeranyl transferase
RxNorm normalized name: geranylgeranylacetone
DrugBank: Teprenone (DB15955)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Geranylgeranyl transferase inhibitor, toxin B, C3 exoenzyme, Y‐27632
Trial: 3966742
Drug: Continuous oxygen
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oxygen therapy
Trial: 8011570
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg and slow release nifedipine 20 mg twice a day
Trial: 2887542
Drug: Beta-adrenergic blockade
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenergic blockade (celiprolol, 600 mg)
Trial: 2887542
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockade (diltiazem, 30 or 60 mg four times daily)
Trial: 29599391
Drug: Collagenase clostridium
RxNorm normalized name: Collagenase Clostridium Histolyticum
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagenase clostridium histolyticum injection followed by limited fasciectomy in non-responsive cases
Trial: 22000583
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose alcohol (1-2 mL)
Trial: 18471252
Drug: Eicosapentaenoic/docosahexaenoic PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic/docosahexaenoic PUFA supplements
Trial: 14638581
Drug: Fluoxetine, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine, 20 mg/day
Trial: 10975513
Drug: Prednisone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (60 mg/m2 per day for 7 days)
Trial: 8470851
Drug: Beclomethasone dipropionate,
RxNorm normalized name: Beclomethasone Dipropionate, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate, 400 micrograms two times daily during years 3 and 4
Trial: 8470851
Drug: Bronchodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator therapy (salbutamol, 400 micrograms, or ipratropium bromide, 40 micrograms) during the first 2 years
Trial: 29777534
Drug: Dental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental treatment provided by a dentist four to five times a week, in addition to routine oral hygiene.
Trial: 24398115
Drug: Dental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental treatment
Trial: 26864095
Drug: Doublebase Dayleve
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doublebase Dayleve gel (DELP)
Trial: 2756353
Drug: Ciprofloxacin 200
RxNorm normalized name: ciprofloxacin 200 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 200 mg b.i.d. iv. for two days, followed by oral administration with 750 mg b.i.d. for a total of 14 days
Trial: 2756353
Drug: Doxycycline plus
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline plus metronidazole according to a similar scheme of administration
Trial: 324570
Drug: Cytotoxic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic treatment (premenopausal women)
Trial: 29920688
Drug: Modified Constraint-Induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Constraint-Induced Movement Therapy (mCIMT)
Trial: 25910378
Drug: LAC (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAC (lansoprazole 1 mg/kg/day, amoxicillin 50 mg/kg/day, clarithromycin 14 mg/kg/day for 14 days)
Trial: 21122499
Drug: Budesonide-MMX(R) 9
RxNorm normalized name: budesonide 9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide-MMX(R) 9 mg tablets
Trial: 16168062
Drug: formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: formoterol 12 microg twice daily
Trial: 10087413
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral methotrexate followed by 800 micrograms vaginal misoprostol 7 days later
Trial: 7587919
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (administered 3 or 4 times a day)
Trial: 27771133
Drug: Unified Protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified Protocol for the Treatment of Emotional Disorders in Adolescents (UP‐A)
Trial: 23292538
Drug: 0.05% betamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% betamethasone valerate cream
Trial: 29194749
Drug: Teriparatide (TPTD)
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide (TPTD) 20 μg/d by subcutaneous injection
Trial: 29194749
Drug: Zoledronic Acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic Acid (ZOL) 5 mg/yr by intravenous infusion
Trial: 25630243
Drug: Glucosamine-sulfate (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucosamine-sulfate (1000 mg daily, for 8 weeks)
Trial: 2051379
Drug: Fixed partial
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed partial dentures with periodontal therapy
Trial: 31004378
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice containing 520 mg nitrate
Trial: 31004378
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice containing 520 mg nitrate and 6 g citrulline
Trial: 31004378
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice containing 520 mg nitrate and 6 g arginine
Trial: 11277826
Drug: Gavestinel (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gavestinel (800 mg loading dose + 200 mg every 12 hours for 3 days), n = 701
Trial: 28029656
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of low LWR and high MWR
Trial: 24050519
Drug: Total delay
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total delay from symptom onset until treatment initiation
Trial: 19036082
Drug: Thalidomide 100
RxNorm normalized name: thalidomide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 100 mg daily plus pulsed dexamethasone 20 mg 4 days a month
Trial: 19036082
Drug: Interferon-alpha 3
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha 3 MU 3 times a week plus pulsed dexamethasone 20 mg 4 days a month
Trial: 17380263
Drug: Needle-free injection
RxNorm normalized name: Stratis Needle-Free Injection Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-free injection system (Intraject) with various device configurations
Trial: 8072258
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) treatment continued for 12 to 60 months
Trial: 8072258
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) treatment with a dosage of up to 5.5 mg/kg/day
Trial: 8072258
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) treatment with a dosage greater than 5.5 mg/kg/day
Trial: 4886627
Drug: Treatment (nitrofurantoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (nitrofurantoin or ampicillin)
Trial: 4886627
Drug: Reinfections post-treatment
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Reinfections post-treatment
Trial: 31194213
Drug: Intracoronary (IC)
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary (IC) tirofiban administration
Trial: 31194213
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) tirofiban administration
Trial: 15456520
Drug: Vinorelbine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine 25 mg/m2 on day 1 and 8, and cisplatin (60 mg/m2 or 70 mg/m2 for older patients; 80 mg/m2 or 90 mg/m2 for younger patients) in 28-day cycles.
Trial: 10806139
Drug: Terbutaline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (1 mg four times a day)
Trial: 10806139
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Terbutaline + Budesonide)
Trial: 1281103
Drug: Serenoa repens
RxNorm normalized name: Serenoa Repens Fruit
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serenoa repens extract (160 mg t.d.) for 3 months
Trial: 3912184
Drug: Bornaprolol (120,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol (120, 240 and 480 mg)
Trial: 27886017
Drug: Physiotherapy twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy twice a week
Trial: 14640990
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (5 microg/kg per day for 1 month and 10 microg/kg per day for 12-30 months)
Trial: 10363394
Drug: Educational seminars
RxNorm normalized name: Semintra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational seminars on generic drugs and computer‐produced prescribing feedback (Intervention group)
Trial: 1775612
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate administration
Trial: 22234017
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 mg capsule orally 1 h before surgery
Trial: 19237781
Drug: Ophthalmic viscosurgical
RxNorm normalized name: Viscoat Ophthalmic Viscosurgical Device Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ophthalmic viscosurgical device (OVD) with balanced salt solution (BSS)
Trial: 28526386
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg/d)
Trial: 11950430
Drug: Reduced-dose alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-dose alteplase plus abciximab
Trial: 15353917
Drug: Reduced-dose alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-dose alteplase plus abciximab (within <2 hours)
Trial: 11576058
Drug: Rocuronium (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (various doses)
Trial: 9211571
Drug: Maprotiline 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline 100 mg daily
Trial: 6124759
Drug: anti‐lymphocyte globulin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anti‐lymphocyte globulin, prednisolone, and azathioprine (3 mg/kg daily after 1 month)
Trial: 6124759
Drug: placebo preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo preparations
Trial: 29048958
Drug: Shade sails
RxNorm normalized name: shad scale pollen extract
DrugBank: Atriplex confertifolia pollen (DB10816)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shade sails at treatment PRAs
Trial: 29048958
Drug: Shade sails
RxNorm normalized name: shad scale pollen extract
DrugBank: Atriplex confertifolia pollen (DB10816)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shade sails at treatment PRAs in Denver
Trial: 24999799
Drug: Olmesartan plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan plus diuretic
Trial: 17037267
Drug: At least
RxNorm normalized name: Lovaza 1000 MG (at least 900 MG) Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: At least one dose vs. placebo
Trial: 17037267
Drug: At least
RxNorm normalized name: Lovaza 1000 MG (at least 900 MG) Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: At least one dose vs. active control
Trial: 12627416
Drug: New treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New treatment at high dose
Trial: 8526696
Drug: Oral quinidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quinidine sulfate (300 mg)
Trial: 3946169
Drug: Oral amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amiodarone
Trial: 8526696
Drug: Oral digoxin/quinidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral digoxin/quinidine
Trial: 28068613
Drug: Brief Behavioral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Behavioral Activation Therapy for Depression (BATD)
Trial: 26304767
Drug: Intact immediate‐release/extended‐release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact immediate‐release/extended‐release oxycodone/acetaminophen 15/650 mg
Trial: 26304767
Drug: Intact immediate‐release/extended‐release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact immediate‐release/extended‐release oxycodone/acetaminophen 30/1,300 mg
Trial: 19172130
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral rehydration solution and feeding advice without zinc)
Trial: 9661646
Drug: Dexamethasone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (2 mg/day for 4 days)
Trial: 2643423
Drug: 38% fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 38% fat treatment diet (9% saturated fat, 15% polyunsaturated fat, 14% monounsaturated fat, 166 mg dietary cholesterol per day)
Trial: 2643423
Drug: 39% fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 39% fat control diet (18% saturated fat, 5% polyunsaturated fat, 16% monounsaturated fat, 446 mg dietary cholesterol per day)
Trial: 2643423
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment and control diets
Trial: 1095962
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg SAMe i.v. or i.m. administered four times a day for 30 days
Trial: 1095962
Drug: Equimolecular doses
RxNorm normalized name: Salicylic acid bimolecular ester
DrugBank: Salsalate (DB01399)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Equimolecular doses of L-methionine and ATP
Trial: 30455321
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus background therapy of mycophenolate and steroids
Trial: 25749542
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy plus famciclovir (antiviral treatment)
Trial: 25749542
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (control group)
Trial: 23429062
Drug: Higher body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher body mass index and less likely to report estrogen or aspirin use
Trial: 19547811
Drug: bromazepam 3
RxNorm normalized name: bromazepam 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromazepam 3 mg
Trial: 16297442
Drug: Prescription-based counseling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription-based counseling and self-monitoring (MON)
Trial: 9241008
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 mg/day on days 8-17 and 100 mg/day on days 18-20)
Trial: 18415758
Drug: 3-l sulphate-free
RxNorm normalized name: 3-(L-MENTHOXY)-2-METHYLPROPANE-1,2-DIOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-l sulphate-free polyethylene glycol solution (SF-PEG)
Trial: 18415758
Drug: 4-l polyethylene
RxNorm normalized name: polyethylene glycol 3350
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-l polyethylene glycol solution (PEG)
Trial: 26672094
Drug: 75-g oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75-g oral glucose tolerance test
Trial: 7772935
Drug: 100-g oral
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-g oral glucose tolerance test
Trial: 2181138
Drug: Antiemetic injections
RxNorm normalized name: metoclopramide
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antiemetic injections of prochlorperazine
Trial: 31221693
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy + Community-based exercise (CBT+EXER) - concurrent over a 12-week period
Trial: 1554179
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg haloperidol IM
Trial: 1554179
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg droperidol IM
Trial: 1554179
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg droperidol IV
Trial: 4033866
Drug: Ethanol (1.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (1.4 ml 100 proof vodka/kg body weight)
Trial: 31368770
Drug: d-cycloserine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-cycloserine (50 mg)
Trial: 9296406
Drug: Ondansetron (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (0.1 mg/kg to 4 mg intravenously)
Trial: 8445378
Drug: Behavioral group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral group therapy (N = 30)
Trial: 3296296
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily beclomethasone dipropionate (500 micrograms/day)
Trial: 3296296
Drug: Four times
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four times daily standard dose inhaler (400 micrograms/day)
Trial: 20935398
Drug: AScVS (anti-scorpion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AScVS (anti-scorpion venom serum) administered as an intravenous slow bolus, ranging from 40 to 100 ml depending on severity
Trial: 20935398
Drug: Prazosin given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin given as 1 mg every 3 h
Trial: 8450893
Drug: Amitriptyline (AM)
DrugBank: Amitriptyline (DB00321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amitriptyline (AM) 50-75 mg
Trial: 2876658
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot) given twice daily
Trial: 2876658
Drug: Ordinary oral
RxNorm normalized name: Azo Urinary Pain Relief Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary oral beta 2-agonist treatment given three times daily
Trial: 2876658
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot)
Trial: 26271141
Drug: Golimumab (GLM)
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Golimumab (GLM) 50 mg every 4 weeks for 48 weeks
Trial: 15620161
Drug: Subcutaneous infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous infiltration between the tibial tuberosity and the internal gastrocnemius muscle
Trial: 11508654
Drug: Sumatriptan 20
RxNorm normalized name: sumatriptan 20 MG/ACTUAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 20 mg intranasally
Trial: 9716275
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy for 2 weeks
Trial: 9716275
Drug: Tryptophan therapy
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tryptophan therapy